Market Overview:
The global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of this market is mainly attributed to the increasing incidence of cancer, technological advancements in interventional oncology procedures and rising demand for minimally invasive treatments. On the basis of type, the global drug eluting beads, microcatheters and radiopaque beads in interventional oncology market is segmented into chemotherapeutic agent-eluting particles, radiation therapy-eluting particles and drug-eluting microspheres. The chemotherapeutic agent-eluting particles segment is expected to account for the largest share of the global market during the forecast period. This can be attributed to increasing use of chemotherapy as a treatment modality for various types of cancer.
Product Definition:
Drug eluting beads (DEBs) are small, porous spheres that can be filled with anticancer drugs. They are designed to release their drug payload slowly over time, which minimizes the systemic exposure of the patient to the chemotherapy agent. This reduces toxicity and makes DEBs a potentially safer option for patients with cancer.
Microcatheters are very thin tubes that can be inserted into very small blood vessels or other body cavities. Their small size allows them to navigate through tight spaces and reach tumors that would otherwise be difficult or impossible to treat surgically.
Radiopaque beads (ROBS) are tiny spheres made of a material that is visible on X-rays and other imaging scans. This allows doctors to track their position inside the body during treatment procedures.
Chemotherapeutic Agent:
Chemotherapeutic agents are drugs used in cancer treatment. They work by damaging the DNA of cancer cells, which then leads to their death. Chemotherapeutic agents can be broadly classified into two types: non-specific and specific (or molecular). Non-specific chemotherapy includes alkylating agents and cytotoxic agents. These affect all forms of cells, but usually with different degrees of toxicity for each cell type.
Radiation Therapy:
Radiation therapy is a treatment using ionizing radiation in medical oncology. It includes external beam radiation therapy, intraoperative radiotherapy, and radioisotope therapy. Ionizing radiation has several effects on the body such as damage to DNA andRNA, disruption of cell reproduction cycle, impairment of normal cell growth & division cycles along with death of cells leading to decreased blood count.
Application Insights:
Based on the application, the global market is segmented into hospitals, specialty clinics and others. Hospitals held the largest share in 2016 owing to a high volume of procedures and wide geographical presence. Drug eluting beads are most commonly used in cancer treatment as they prevent tumor cells from adhering to walls of blood vessels which leads to increased circulation time and decreased blood supply to tumor site for effective drug delivery system. This factor is anticipated to fuel growth over next seven years.
Specialty clinics are expected register fastest CAGR during forecast period due largely their preference towards less invasive procedures coupled with an increasing number of complex surgeries that require precise placement of devices for better results leading eventually in higher adoption rate compared with hospitals.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement scenario, high healthcare expenditure, and increasing awareness about emerging technologies. Moreover, presence of key players in this region is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising target population base and improving healthcare infrastructure coupled with economic development in this region will boost industry expansion over next eight years. In addition, growing number of clinical trials being conducted for various types of cancer may further propel demand for interventional oncology products during the forecast period (2018-2030).
Moreover, government support aimed at reducing treatment cost by promoting generic drugs usage is also expected favorably impact industry expansion over next eight years’ time span.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the drug eluting beads, microcatheters and radiopaque beads in interventional oncology market. According to American Cancer Society, approximately 1,685,210 new cases of cancer will be diagnosed in the U.S. in 2017 and about 600,920 people will die from the disease. This number is expected to rise significantly in next few years due to increase in aging population and unhealthy lifestyle habits such as smoking and alcohol consumption.
- Rising demand for minimally invasive procedures: The growing demand for minimally invasive procedures is another key factor driving growth of drug eluting beads, microcatheters and radiopaque beads market in interventional oncology sector. These devices offer several advantages over traditional open surgery such as shorter hospital stay time, reduced pain & blood loss and faster recovery time period which has led to their increasing adoption among patients worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Research Report
By Type
Chemotherapeutic Agent, Radiation Therapy, Drug-eluting Particles
By Application
Hospitals, Specialty Clinics
By Companies
Abbott Laboratories (Abbott EP), ABK Biomedical, Inc., Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Medtronic, Inc., Merit Medical Systems, Inc., Stryker Corporation, TriSalus Life Sciences, Terumo Corporation, Vascular Solutions, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
217
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Report Segments:
The global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology market is segmented on the basis of:
Types
Chemotherapeutic Agent, Radiation Therapy, Drug-eluting Particles
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories (Abbott EP)
- ABK Biomedical, Inc.
- Boston Scientific Corporation
- BTG plc
- Cook Medical, Inc.
- Medtronic, Inc.
- Merit Medical Systems, Inc.
- Stryker Corporation
- TriSalus Life Sciences
- Terumo Corporation
- Vascular Solutions, Inc.
Highlights of The Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapeutic Agent
- Radiation Therapy
- Drug-eluting Particles
- By Application:
- Hospitals
- Specialty Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug eluting beads, microcatheters and radiopaque beads are used in interventional oncology to deliver chemotherapy or other treatments directly to the tumor.
Some of the major companies in the drug eluting beads, microcatheters and radiopaque beads in interventional oncology market are Abbott Laboratories (Abbott EP), ABK Biomedical, Inc., Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Medtronic, Inc., Merit Medical Systems, Inc., Stryker Corporation, TriSalus Life Sciences, Terumo Corporation, Vascular Solutions, Inc..
The drug eluting beads, microcatheters and radiopaque beads in interventional oncology market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size & Forecast, 2018-2028
4.5.1 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size and Y-o-Y Growth
4.5.2 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Absolute $ Opportunity
Chapter 5 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Type
5.2.1 Chemotherapeutic Agent
5.2.2 Radiation Therapy
5.2.3 Drug-eluting Particles
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Analysis and Forecast
9.1 Introduction
9.2 North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Type
9.6.1 Chemotherapeutic Agent
9.6.2 Radiation Therapy
9.6.3 Drug-eluting Particles
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Type
10.6.1 Chemotherapeutic Agent
10.6.2 Radiation Therapy
10.6.3 Drug-eluting Particles
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Type
11.6.1 Chemotherapeutic Agent
11.6.2 Radiation Therapy
11.6.3 Drug-eluting Particles
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Type
12.6.1 Chemotherapeutic Agent
12.6.2 Radiation Therapy
12.6.3 Drug-eluting Particles
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Type
13.6.1 Chemotherapeutic Agent
13.6.2 Radiation Therapy
13.6.3 Drug-eluting Particles
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market: Competitive Dashboard
14.2 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories (Abbott EP)
14.3.2 ABK Biomedical, Inc.
14.3.3 Boston Scientific Corporation
14.3.4 BTG plc
14.3.5 Cook Medical, Inc.
14.3.6 Medtronic, Inc.
14.3.7 Merit Medical Systems, Inc.
14.3.8 Stryker Corporation
14.3.9 TriSalus Life Sciences
14.3.10 Terumo Corporation
14.3.11 Vascular Solutions, Inc.
